|
[1]FIERER N,BARBERN A,LAUGHLIN DC.Seeing the forest for the genes:using metagenomics to infer the aggregated traits of microbial communities[J].Front Microbiol,2014,5(614):30-34.
|
|
[2]HANDELSMAN J,RONDON MR,BRADY SF,et al.Molecular biological access to the chemistry of unknown soil microbes:a new frontier for natural products[J].Chem Biol,1998,5(10):r245-r249.
|
|
[3]LOZUPONE CA,STOMBAUGH JI,GORDON JI,et al.Diversity,stability and resilience of the human gut microbiota[J].Nature,2012,489(7415):220-230.
|
|
[4]QIN J,LI R,RAES J,et al.A human gut microbial gene catalogue established by metagenomic sequencing[J].Nature,2010,464(7285):59-65.
|
|
[5]HOLLISTER EB,RIEHLE K,LUNA RA,et al.Structure and function of the healthy pre-adolescent pediatric gut microbiome[J].Microbiome,2015,3:36.
|
|
[6]CLAESSON MJ,JEFFERY IB,CONDE S,et al.Gut microbiota composition correlates with diet and health in the elderly[J].Nature,2012,488(7410):178-184.
|
|
[7]MACFARLANE GT,MACFARLANE S.Fermentation in the human large intestine:its physiologic consequences and the potential contribution of prebiotics[J].J Clin Gastroenterol,2011,45(Suppl):s120-s127.
|
|
[8]KIM MH,KANG SG,PARK JH,et al.Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice[J].Gastroenterology,2013,145(2):396-406.
|
|
[9]BUFFIE CG,BUCCI V,STEIN RR,et al.Precision microbiome reconstitution restores bile acid mediated resistance to clostridium difficile[J].Nature,2015,517(7533):205-208.
|
|
[10]ZELANTE T,IANNITTI RG,CUNHA C,et al.Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22[J].Immunity,2013,39(2):372-385.
|
|
[11]HAMER HM,de PRETER V,WINDEY K,et al.Functional analysis of colonic bacterial metabolism:relevant to health?[J].Am JPhysiol Gastrointest Liver Physiol,2012,302(1):g1-g9.
|
|
[12]USAMI M,MIYOSHI M,YAMASHITA H.Gut microbiota and host metabolism in liver cirrhosis[J].World J Gastroenterol,2015,21(41):11597-11608.
|
|
[13]MINEMURA M,SHIMIZU Y.Gut microbiota and liver diseases[J].World J Gastroenterol,2015,21(6):1691-1702.
|
|
[14]SIOBHAN F,CLARKE,EILEEN F,et al.The gut microbiota and its relationship to diet and obesity:new insights[J].Gut Microbes,2012,3(3):186-202.
|
|
[15]YILMAZ Y,YOUNOSSI ZM.Obesity-associated nonalcoholic fatty liver disease[J].Clin Liver Dis,2014,18(1):19-31.
|
|
[16]MOUZAKI M,COMELLI EM,ARENDT BM,et al.Intestinal microbiota in patients with nonalcoholic fatty liver disease[J].Hepatology,2013,58(1):120-127.
|
|
[17]MA YY,LI L,YU CH,et al.Effects of probiotics on nonalcoholic fatty liver disease:a meta-analysis[J].World J Gastroenterol,2013,19(40):6911-6918.
|
|
[18]ZHU L,BAKER SS,GILL C,et al.Characterization of gut microbiomes in nonalcoholic steatohepatitis(NASH)patients:a connection between endogenous alcohol and NASH[J].Hepatology,2013,57(2):601-609.
|
|
[19]IMAJO K,FUJITA K,YONEDA M,et al.Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling[J].Cell Metab,2012,16(1):44-54.
|
|
[20]MIURA K,KODAMA Y,INOKUCHI S,et al.Toll-like receptor9 promotes steatohepatitis by induction of interleukin-1beta in mice[J].Gastroenterology,2010,139(1):323-334.
|
|
[21]QIN N,YANG F,LI A,et al.Alterations of the human gut microbiome in liver cirrhosis[J].Nature,2014,513(7516):59-64.
|
|
[22]KAKIYAMA G,PANDAK WM,GILLEVET PM,et al.Modulation of the fecal bile acid profile by gut microbiota in cirrhosis[J].JHepatol,2013,58(5):949-955.
|
|
[23]BAJAJ JS,RIDLON JM,HYLEMON PB,et al.Linkage of gut microbiome with cognition in hepatic encephalopathy[J].Am J Physiol Gastrointest Liver Physiol,2012,302(1):g168-g175.
|
|
[24]ZHANG HL,YU LX,YANG W,et al.Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats[J].J Hepatol,2012,57(4):803-812.
|
|
[25]SEKI E,de MINICIS S,OSTERREICHER CH,et al.TLR4 enhances TGF-beta signaling and hepatic fibrosis[J].Nat Med,2007,13(11):1324-1332.
|
|
[26]PAIK YH,SCHWABE RF,BATALLER R,et al.Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in humanhepatic stellate cells[J].Hepatology,2003,37(5):1043-1055.
|
|
[27]CHEN Y,QIN N,GUO J,et al.Functional gene arrays-based analysis of fecal microbiomes in patients with liver cirrhosis[J].BMC Genomics,2014,15:753.
|
|
[28]DAPITO DH,MENCIN A,GWAK GY,et al.Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4[J].Cancer Cell,2012,21(4):504-516.
|
|
[29]YOSHIMOTO S,LOO TM,ATARASHI K,et al.Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome[J].Nature,2013,499(7456):97-101.
|
|
[30]SUNG CY,LEE NP,EL-NEZAMI H.Regulation of T Helper 17by bacteria:an approach for the treatment of hepatocellular carcinoma[J].Int J Hepatol,2012,2012:439024.
|
|
[31]LI J,SUNG CY,LEE N,et al.Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice[J].Proc Natl Acad Sci U S A,2016,113(9):e1306-e1315.
|
|
[32]BINDELS LB,PORPORATO P,DEWULF EM,et al.Gut microbiota-derived propionate reduces cancer cell proliferation in the liver[J].Br J Cancer,2012,107(8):1337-1344.
|
|
[33]O'TOOLE A,ALAKKARI A,KEEGAN D,et al.Primary sclerosing cholangitis and disease distribution in inflammatory bowel disease[J].Clin Gastroenterol Hepatol,2012,10(4):439-441.
|
|
[34]SANO H,NAKAZAWA T,ANDO T,et al.Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis[J].J Hepatobiliary Pancreat Sci,2011,18(2):154-161.
|
|
[35]LICHTMAN SN,KEKU J,CLARK RL,et al.Biliary tract disease in rats with experimental small bowel bacterial overgrowth[J].Hepatology,1991,13(4):766-772.
|
|
[36]RUDOLPH G,GOTTHARDT D,KLTERS-PLACHKY P,et al.Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis[J].J Hepatol,2009,51(1):149-155.
|
|
[37]KUMMEN M,HOLM K,ANMARKRUD JA,et al.The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls[J].Gut,2016.pii:gutjnl-2015-310500.
|
|
[38]MOLYNEAUX PL,COX MJ,WILLIS-OWEN SA,et al.The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis[J].Am J Respir Crit Care Med,2014,190(8):906-913.
|
|
[39]TORRES J,BAO X,GOEL A,et al.The features of mucosa-associated microbiota in primary sclerosing cholangitis[J].Aliment Pharmacol Ther,2016,43(7):790-801.
|
|
[40]ROSSEN NG,FUENTES S,BOONSTRA K,et al.The mucosaassociated microbiota of PSC patients is characterized by low diversity and low abundance of uncultured Clostridiales II[J].J Crohns Colitis,2015,9(4):342-348.
|
|
[41]ATARASHI K,TANOUE T,OSHIMA K,et al.Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota[J].Nature,2013,500(7461):232-236.
|
|
[42]SABINO J,VIEIRA-SILVA S,MACHIELS K,et al.Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD[J].Gut,2016.pii:gutjnl-2015-311004.
|
|
[43]TABIBIAN JH,O'HARA SP,TRUSSONI CE,et al.Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model ofprimary sclerosing cholangitis[J].Hepatology,2016,63(1):185-196.
|
|
[44]TABIBIAN JH,TALWALKAR JA,LINDOR KD.Role of the microbiota and antibiotics in primary sclerosing cholangitis[J].Biomed Res Int,2013,2013:389537.
|
|
[45]BOGDANOS DP,BAUM H,GRASSO A,et al.Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis[J].J Hepatol,2004,40(1):31-39.
|
DownLoad: